Resources

Explore our online resource catalog to discover publications, presentations, tools, and related resources for global health practitioners, decision-makers, advocates, and more.

All resources

Read our latest

2323 Result s
2323 Result s
    Date
    From
    To
  1. This study aimed to monitor vector behavior, species composition, and vector susceptibility to insecticides used for malaria vector control to guide the malaria elimination agenda. Outdoor biting, early biting, pyrethroid insecticide resistance, and carbamate insecticide resistance were identified and could undermine elimination efforts. Additional interventions and sustainable insecticide resistance management strategies are likely to be required.
    Published: November 2016
    Resource Page
    Part of a Series
  2. The objective of the study was to evaluate whether case investigation with focal testing and focal drug administration can decrease malaria incidence. The lack of impact attributable to the program may have been due to the large increase in cases and subsequent imperfect case investigation, with 33% of eligible cases not investigated.
    Published: November 2016
    Resource Page
    Part of a Series
  3. This poster, which focuses on data from Ethiopia and Senegal, shows that differences between DHIS2 and the facility source records are small and decreased from 2013 to 2014, suggesting that the system can provide accurate and timely information on malaria transmission intensity at the health-post level.
    Published: November 2016
    Resource Page
    Part of a Series
  4. Real-time, accurate, and actionable data are critical for malaria elimination; using dashboards to visualize malaria data in Zambia is one possible solution to strengthen feedback loops to the most granular levels and motivate end users. To make dashboards matter, dashboards should be developed jointly with eventual end users and focus on tools for practical decision-making.
    Published: November 2016
    Resource Page
    Part of a Series
  5. This poster demonstrates that the use of DHAp for malaria treatment was generally safe and well tolerated. A total of 687 adverse events (AEs) were reported (0.13% of participants, 0.24% of treatments). Four AEs were initially reported as serious adverse events, though three were later identified as not related to drug ingestion.
    Published: November 2016
    Resource Page
    Part of a Series